Showing results (31-40 of 72) with videos related to
Sort By:
Pageof 8
The European Respiratory Journal|January 1, 1994
Serum tumour markers in lung cancer: history, biology and clinical applicationsD Ferrigno, G Buccheri, A BiggiMonaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 12, 1999
Serum copper and zinc content in non-small cell lung cancer: abnormalities and clinical correlatesD Ferrigno, G Buccheri, T CamillaEuropean Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institutionG Buccheri, D Ferrigno, M TamburiniMonaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|August 18, 2006
Weekly chemotherapy with cisplatin and paclitaxel in advanced NSClC: a phase II studyG Buccheri, D Ferrigno, M C GiordanoSupportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 2, 2000
The difficult choice of chemotherapy in patients with unresectable non-small-cell lung cancerM Tamburini, G Buccheri, C Brunelli, et al.Tumori|February 28, 1989
Yield of total body GA-67 scintigraphy in the staging of non-small cell lung cancerG Buccheri, F Vola, D Ferrigno, et al.Oncology|January 1, 1989
Combination chemotherapy with methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) for nonsmall cell lung cancer. 4-year experience with 92 patientsG Buccheri, D Ferrigno, F Vola, et al.Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|February 1, 1986
MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancerG Buccheri, D Ferrigno, A Curcio, et al.European Journal of Respiratory Diseases|November 1, 1987
Lack of clinical significance of gallium-67 uptake in non-small cell lung cancerG Buccheri, F Vola, D Ferrigno, et al.Chest|June 1, 1991
Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity?G Buccheri, P Marino, A Preatoni, et al.Pageof 8